Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Certain genes and nutrients like vitamin D, zinc, and omega fatty acids affect COVID-19 severity and infection risk.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Minoxidil foam helps hair growth by increasing good proteins and decreasing bad pathways in men with hair loss.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hair follicles have a more inactive cell cycle than other skin cells, which may help develop targeted therapies for skin diseases and cancer.

The research concluded that selection significantly shaped the genetic variation of the X chromosome, with certain regions affected by past selective events.

No significant link between male pattern baldness and COVID-19 severity was found.

Melatonin affects different genes and pathways important for goat hair growth.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Hairless protein is key for hair growth, cell differences cause gene expression variation, and the N-end rule pathway senses nitric oxide for protein breakdown.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Long COVID patients may have hormonal imbalances linked to their symptoms.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Male pattern hair loss could hint at androgens affecting COVID-19 severity.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Insulin resistance linked to obesity may increase COVID-19 severity.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.